Should minimal blood glucose variability become the gold standard of glycemic control?, Journal of Diabetes and its Complications, vol.19, issue.3, pp.178-181, 2005. ,
DOI : 10.1016/j.jdiacomp.2004.10.001
Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring, Diabetes Care, vol.29, issue.12, pp.2730-2732, 2006. ,
DOI : 10.2337/dc06-1134
Sensor-Augmented Insulin Pump Therapy: Results of the First Randomized Treat-to-Target Study, Diabetes Technology & Therapeutics, vol.10, issue.5, pp.377-383, 2008. ,
DOI : 10.1089/dia.2008.0068
Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial, Diabetologia, vol.114, issue.7, pp.1250-1257, 2009. ,
DOI : 10.1007/s00125-009-1365-0
Incremental Value of Continuous Glucose Monitoring When Starting Pump Therapy in Patients With Poorly Controlled Type 1 Diabetes: The RealTrend study, Diabetes Care, vol.32, issue.12, pp.2245-2250, 2009. ,
DOI : 10.2337/dc09-0750
URL : https://hal.archives-ouvertes.fr/hal-00448802
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes, New England Journal of Medicine, vol.363, issue.4, pp.311-320, 2010. ,
DOI : 10.1056/NEJMoa1002853
Assessment of Patient-Led or Physician-Driven Continuous Glucose Monitoring in Patients With Poorly Controlled Type 1 Diabetes Using Basal-Bolus Insulin Regimens: A 1-year multicenter study, Diabetes Care, vol.35, issue.5, pp.965-971, 2012. ,
DOI : 10.2337/dc11-2021
Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data, BMJ, vol.343, issue.jul07 1, p.3805, 2011. ,
DOI : 10.1136/bmj.d3805
Use of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes on Multiple Daily Injections Versus Continuous Subcutaneous Insulin Infusion Therapy: A prospective 6-month study, Diabetes Care, vol.34, issue.3, pp.574-579, 2011. ,
DOI : 10.2337/dc10-1852
Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes, Diabetes Care, vol.34, issue.4, pp.795-800, 2011. ,
DOI : 10.2337/dc10-1989
Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia, New England Journal of Medicine, vol.369, issue.3, pp.224-232, 2013. ,
DOI : 10.1056/NEJMoa1303576
Reduction of severe hypoglycemia with sensoraugmented insulin pump therapy and automated insulin suspension in patients with type 1 diabetes, Diabetes, vol.62, issue.1, p.228, 2013. ,
Postprandial Hyperglycemia and Diabetes Complications: Is It Time to Treat?, Diabetes, vol.54, issue.1, pp.1-7, 2005. ,
DOI : 10.2337/diabetes.54.1.1
Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor: A randomized controlled trial, Diabetes Care, vol.29, issue.1, pp.44-50, 2006. ,
DOI : 10.2337/diacare.29.01.06.dc05-1686
Use of a real-time continuous glucose monitoring system in children and young adults on insulin pump therapy: patients' and caregivers' perception of benefit, Pediatric Diabetes, vol.7, issue.3, pp.182-187, 2010. ,
DOI : 10.1111/j.1399-5448.2009.00549.x
Determining Clinical and Psychological Benefits and Barriers with Continuous Glucose Monitoring Therapy, Diabetes Technology & Therapeutics, vol.12, issue.3, pp.201-205, 2010. ,
DOI : 10.1089/dia.2009.0121
Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump, J Diabetes Sci Technol, vol.3, pp.1402-1410, 2009. ,
The Cost-Effectiveness of Continuous Glucose Monitoring in Type 1 Diabetes, Diabetes Care, vol.33, issue.6, pp.1269-1274, 2010. ,
DOI : 10.2337/dc09-2042
Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes, Cost Effectiveness and Resource Allocation, vol.9, issue.1, p.13, 2011. ,
DOI : 10.2337/diacare.28.3.617
Continuous glucose monitoring: coming of age?, European Journal of Endocrinology, vol.166, issue.1, pp.1-4, 2012. ,
DOI : 10.1530/EJE-10-1127
Realistic Expectations and Practical Use of Continuous Glucose Monitoring for the Endocrinologist, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.7, pp.2232-2238, 2009. ,
DOI : 10.1210/jc.2008-2625
Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial, Diabetologia, vol.114, issue.7, pp.1250-1257, 2009. ,
DOI : 10.1007/s00125-009-1365-0
Evaluation of an Algorithm to Guide Patients With Type 1 Diabetes Treated With Continuous Subcutaneous Insulin Infusion on How to Respond to Real-Time Continuous Glucose Levels: A randomized controlled trial, Diabetes Care, vol.33, issue.6, pp.1242-1248, 2010. ,
DOI : 10.2337/dc09-1481
An Algorithm Guiding Patient Responses to Real-Time-Continuous Glucose Monitoring Improves Quality of Life, Diabetes Technology & Therapeutics, vol.13, issue.2, pp.105-109, 2011. ,
DOI : 10.1089/dia.2010.0139
P1122 ??valuation de l???observance ?? la mesure en continu du glucose dans le cadre de l???accompagnement du patient diab??tique de type 1 trait?? par pompe ?? insuline, Diabetes & Metabolism, vol.39, issue.1, p.60, 2013. ,
DOI : 10.1016/S1262-3636(13)71868-8
La mesure en continu du glucose: quel impact sur l'équilibre glycémique? Quelles indications? Comment l'utiliser en pratique? Mises au point cliniques d, Endocrinologie, vol.2010, pp.107-123 ,
Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: Consensus of experts from SFD, EVADIAC and SFE, Diabetes & Metabolism, vol.38, issue.4, pp.67-83, 2012. ,
DOI : 10.1016/S1262-3636(12)71538-0
Therapeutic Patient Education ? Continuing Education Programmes for health care providers in the field of chronic disease, 1996. ,
Education thérapeutique : questions et controverses. Education thérapeutique : la mise en oeuvre. Paris : Editions scientifiques L&C, 2012. ,
JORF n°0245 du 21 octobre 2010 ,
La télémédecine au service de la prise en charge des patients diabétiques. Développements actuels et conditions du succès. Education thérapeutique et progrès techniques, 2013. ,
The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA1c in Poorly Controlled Type 1 Diabetic Patients: A 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study), Diabetes Care, vol.34, issue.3, pp.533-539, 2011. ,
DOI : 10.2337/dc10-1259
URL : https://hal.archives-ouvertes.fr/inserm-00628821
An overview of continuous glucose monitoring and the ambulatory glucose profile, Minn Med, vol.94, issue.8, pp.40-44, 2011. ,
Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies, BMJ, vol.342, issue.apr13 5, p.1855, 2011. ,
DOI : 10.1136/bmj.d1855
Fully Integrated Artificial Pancreas in Type 1 Diabetes: Modular Closed-Loop Glucose Control Maintains Near Normoglycemia, Diabetes, vol.61, issue.9, pp.2230-2237, 2012. ,
DOI : 10.2337/db11-1445